Twist Bioscience (TWST) has disclosed a new risk, in the Manufacturing category.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Twist Bioscience faces a significant risk in its ability to scale manufacturing capacity to meet future demand, which could adversely impact its business operations. Although the current capacity meets existing demand, the unpredictability of future demand poses a challenge, potentially leading to excess inventory and financial losses. The complexity of their technology and production processes may result in unforeseen difficulties, diverting resources from other product offerings. Failure to expand manufacturing capacity efficiently could materially harm their business, financial condition, and operational results.
The average TWST stock price target is $40.40, implying 52.68% upside potential.
To learn more about Twist Bioscience’s risk factors, click here.